Show simple item record

dc.contributor.advisorWilliams, John H. H.
dc.contributor.authorPowell, Diane E.*
dc.date.accessioned2009-08-07T11:38:45Z
dc.date.available2009-08-07T11:38:45Z
dc.date.issued2006-10
dc.identifieruk.bl.ethos.441933
dc.identifier.citationPowell, D.E., Johnson, W.E., Marshall, M.J., Mangham, D.C., Williams, J.H.H., & Davie, M.W.J. (2004). Effect of bone extracts on the receptor activator of nuclear factor-kB ligand/osteoprotegerin system in osteoblast-like cells. Calcified Tissue International, 74, S48.
dc.identifier.citationPowell, D.E., Johnson, W.E., Marshall, M.J., Williams, J.H.H., & Davie, M.W.J. (2005). Bone extracts can stimulate the secretion of osteoprotegerin the osteosarcoma cell lines MG-63 and Saos-2. Journal of Bone and Mineral Research, 20, 1305.
dc.identifier.citationPowell, D.E., Johnson, W.E., Marshall, M.J., Williams, J.H.H., Kukita, T., & Davie, M.W.J. (2007). Bone matrix extracts directly and indirectly stimulates bone reorption. Calcified Tissue International, 80 Supplement 1, S92-93.
dc.identifier.urihttp://hdl.handle.net/10034/76642
dc.description.abstractBone remodelling is a complex process, which involves the coupling of bone formation to completed foci of bone resorption, the balance between these 2 processes determines if bone is lost or gained at a particular site. During bone resorption osteoclasts release growth factors sequestered in bone matrix, which are thought to initiate new bone formation. On the other hand, osteoblasts can regulate osteoclast activity through the expression of the counter-acting cytokines, RANKL and OPG. The aim of this project was to determine if factors released during bone resorption impact on the RANKL/OPG system or on osteoclasts directly to regulate bone remodelling. OPG secretion was characterized in a number of osteoblast-like cells and the osteosarcoma cell line MG-63 was chosen as a model for osteoblastic cell behaviour in vitro. EDTA bone extracts prepared from normal human cortical bone powder were used to treat MG-63 cells in vitro. The response to the extract was dependent on the purification procedure used. OPG production was inhibited by partially purified extracts prepared using hydrophobic interaction chromatography, C18 SPE. In comparison extracts prepared using size exclusion centrifugal filters stimulated OPG secretion in confluent MG-63 cells. Therefore bone matrix constituents were able to influence osteoclast activity directly and indirectly through the osteoblastic cells to produce the same response. The simplest mechanism for this co-ordinated response would be the presence of one factor in the extract that is able to influence both osteoblasts and osteoclasts. The identity of the factor responsible for the opposing effects seen in the bone matrix extracts is at the moment unknown. The work presented in this thesis clearly demonstrated that unknown growth factors present in bone matrix influence bone remodelling.
dc.language.isoenen
dc.publisherUniversity of Liverpool (University of Chester)
dc.subjectbone matrix extracten
dc.subjectbone cell activityen
dc.subjectbone remodellingen
dc.titleThe effect of bone matrix extract on bone cell activityen
dc.typeThesis or dissertationen
dc.type.qualificationnamePhDen
dc.type.qualificationlevelDoctoralen
html.description.abstractBone remodelling is a complex process, which involves the coupling of bone formation to completed foci of bone resorption, the balance between these 2 processes determines if bone is lost or gained at a particular site. During bone resorption osteoclasts release growth factors sequestered in bone matrix, which are thought to initiate new bone formation. On the other hand, osteoblasts can regulate osteoclast activity through the expression of the counter-acting cytokines, RANKL and OPG. The aim of this project was to determine if factors released during bone resorption impact on the RANKL/OPG system or on osteoclasts directly to regulate bone remodelling. OPG secretion was characterized in a number of osteoblast-like cells and the osteosarcoma cell line MG-63 was chosen as a model for osteoblastic cell behaviour in vitro. EDTA bone extracts prepared from normal human cortical bone powder were used to treat MG-63 cells in vitro. The response to the extract was dependent on the purification procedure used. OPG production was inhibited by partially purified extracts prepared using hydrophobic interaction chromatography, C18 SPE. In comparison extracts prepared using size exclusion centrifugal filters stimulated OPG secretion in confluent MG-63 cells. Therefore bone matrix constituents were able to influence osteoclast activity directly and indirectly through the osteoblastic cells to produce the same response. The simplest mechanism for this co-ordinated response would be the presence of one factor in the extract that is able to influence both osteoblasts and osteoclasts. The identity of the factor responsible for the opposing effects seen in the bone matrix extracts is at the moment unknown. The work presented in this thesis clearly demonstrated that unknown growth factors present in bone matrix influence bone remodelling.


Files in this item

Thumbnail
Name:
introductory materials.pdf
Size:
504.3Kb
Format:
PDF
Request:
Introductory Materials
Thumbnail
Name:
chapter 1.pdf
Size:
4.418Mb
Format:
PDF
Request:
Introduction
Thumbnail
Name:
chapter 2.pdf
Size:
267.3Kb
Format:
PDF
Request:
Methods
Thumbnail
Name:
chapter 3.pdf
Size:
2.751Mb
Format:
PDF
Request:
An Examination of the Osteogenic ...
Thumbnail
Name:
chapter 4.pdf
Size:
3.845Mb
Format:
PDF
Request:
The Effect of Bone Matrix ...
Thumbnail
Name:
chapter 5.pdf
Size:
4.022Mb
Format:
PDF
Request:
The Development of an Osteoclast ...
Thumbnail
Name:
chapter 6.pdf
Size:
1.485Mb
Format:
PDF
Request:
Discussion
Thumbnail
Name:
references.pdf
Size:
2.669Mb
Format:
PDF
Request:
References

This item appears in the following Collection(s)

Show simple item record